Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

  • There is currently no data for BIOM

Pre-close Trading Statement

22 Jan 2015 07:00

RNS Number : 8100C
Biome Technologies PLC
22 January 2015
 



22 January 2015

 

Biome Technologies plc

("Biome" or "the Group")

 

 

Pre-close Trading Statement

 

 

Biome Technologies plc is pleased to provide a pre-close trading statement for the financial year ended 31 December 2014.

 

The Board expects the financial performance for the full year period to be in line with management's expectations. Group revenues for the year reached £3.6m, representing an 81% increase on revenues of £2.0m in 2013.

Revenues in the Bioplastics division were subdued in the fourth quarter at £0.2m (Q3 2014: £0.1m). Offtake to the single-serve coffee market in the USA remained compromised by competitive challenges to the brewing technology of Biome's main customer. The Board understands that this problem has been resolved technically, albeit demand has yet to normalise. Customer trials for Biome's innovative high temperature material for food service applications continue to be encouraging. Substantial progress has been made towards obtaining further grant support from Innovate UK for Biome's activity in researching the transformation of lignin to bioplastics and finalisation of a new grant is expected in the near future.

 

The RF division finished the year in a robust manner, with final quarter revenues of £0.6m (Q3 2014: £0.4m), generated across a number of sectors. Shipments of the first of the division's new range of fibre optic furnaces have been made utilising technology that significantly improves energy efficiency. Ten pre-production pipe-welding units were completed for Durapipe as expected in the final quarter. The order book for 2015 is building well, underpinned by the contract for a regulated industrial customer as previously announced..

 

The Group's cash position at 31 December 2014 was £2.4m (30 September 2014: £2.8m).

 

The audited preliminary results for the year ended 31 December 2014 are scheduled to be published on 25 March 2015.

 

 

-Ends-

 

 

 

For further information please contact:

 

Biome Technologies plc

Paul Mines, Chief Executive Officer

Declan Brown, Group Finance Director

w.biometechnologiesplc.com

Tel: +44 (0) 2380 867 100

Allenby Capital

David Hart (Nomad)

Chris Crawford/Kelly Gardiner (Broker)

www.allenbycapital.com

Tel: +44 (0) 20 3002 2070

FTI Consulting

Oliver Winters

www.fticonsulting.com

Tel: +44 (0) 20 3727 1535

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDFLFLEFFXBBF
Date   Source Headline
29th Jan 20157:00 amRNSOperational Update
22nd Jan 20157:00 amRNSPre-close Trading Statement
21st Jan 20154:35 pmRNSHolding(s) in Company
11th Dec 201410:11 amRNSChange of Adviser
14th Nov 20149:58 amRNSHolding(s) in Company
4th Nov 20147:00 amRNSTrading Update
3rd Sep 20147:00 amRNSInterim Results
12th Aug 20149:36 amRNSHolding(s) in Company
31st Jul 20147:00 amRNSContract progress for RF Technologies Business
24th Jul 20143:28 pmRNSTrading Update
6th Jun 20143:56 pmRNSHolding(s) in Company
7th May 20147:00 amRNSEMI Share Option Plan
23rd Apr 201412:26 pmRNSResult of AGM and Appointment of Director
23rd Apr 20147:00 amRNSTrading Update
31st Mar 20147:00 amRNSUpdated Corporate Presentation
28th Mar 20147:02 amRNSPosting of Notice of AGM & Annual Report
27th Mar 20147:00 amRNSPreliminary Results
24th Mar 201411:43 amRNSContract for Stanelco RF Technologies Division
19th Feb 20149:01 amRNSHolding(s) in Company
24th Jan 20147:00 amRNSPre-close Trading Statement
4th Dec 20133:37 pmRNSIssue of Shares to Director
28th Nov 20131:30 pmRNSDirector/PDMR Shareholding
27th Nov 20137:00 amRNSHolding(s) in Company
4th Nov 20137:00 amRNSTrading Update
31st Oct 201312:27 pmRNSTotal Voting Rights
2nd Oct 201312:47 pmRNSIssue of Shares to a Director
27th Sep 20138:51 amRNSTR-1: Notification of Major Interest in Shares
25th Sep 201312:33 pmRNSResult of General Meeting
2nd Sep 20137:10 amRNSNotice of General Meeting
2nd Sep 20137:00 amRNSInterim Results
26th Jul 20137:00 amRNSPurchase of Shares following Consolidation
18th Jul 20137:00 amRNSInterim Management Statement
20th Jun 20132:34 pmRNSIssue of Equity
20th Jun 201312:45 pmRNSResult of General Meeting
17th Jun 201312:01 pmRNSHolding(s) in Company
17th Jun 201311:59 amRNSHolding(s) in Company
23rd May 20137:01 amRNSCapital Reorganisation
23rd May 20137:00 amRNSSettlement with Landlord in Respect of Leases
26th Apr 20137:00 amRNSIssue of shares to a Director Total Voting rights
25th Apr 20134:10 pmRNSResult of AGM
25th Apr 20137:00 amRNSTrading Update
4th Apr 20137:00 amRNSResearch Grant Award
3rd Apr 20134:35 pmRNSNotice of AGM and Annual Report and Accounts
28th Mar 20137:10 amRNSDirector's Remuneration and Consultancy agreement
28th Mar 20137:01 amRNSPreliminary Results
23rd Jan 20137:00 amRNSPre-close Trading Statement
2nd Nov 20127:00 amRNSTrading Update
1st Oct 20123:24 pmRNSCompletion of Sale
27th Sep 20122:03 pmRNSResult of General Meeting
7th Sep 20127:00 amRNSProposed Sale of stake in Biotec Holding GmbH

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.